Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture: Clinical Vs Science in Personalizing Immunosuppression
Recorded On: 11/10/2019
Immunosuppression in the liver transplant setting includes multiple drugs aimed at predetermined trough levels, adjusted to time after transplantation. Excellent graft and patient survival supports immunosuppression, but there may be significant short- and long-term risks. At this presentation, experts will discuss clinical approaches to immunosuppression in liver transplant patients, including biomarkers used for safe personalization of this process.